STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

BioLife Solutions (NASDAQ: BLFS) will release its third quarter 2025 financial results after market close on Thursday, November 6, 2025. Management will host a conference call and live webcast the same day at 4:30 PM ET (1:30 PM PT) to present an overview of financial results and a general business update.

Investors can access the live webcast at the company Investor Relations page and join the call via toll-free 1-833-630-0431 or international 1-412-317-1808. A replay will be available about two hours after the call and archived on the investor site for 90 days.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.45% News Effect

On the day this news was published, BLFS gained 0.45%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOTHELL, Wash., Oct. 23, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's third quarter 2025 financial results will be released after market close on Thursday, November 6, 2025. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com/ for 90 days.

About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations         

At the Company
Troy Wichterman           
Chief Financial Officer          
(425) 402-1400          
twichterman@biolifesolutions.com 

Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-third-quarter-2025-financial-results-and-business-update-on-november-6-2025-302592006.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions (BLFS) release Q3 2025 results?

BioLife Solutions will release Q3 2025 results after market close on November 6, 2025.

What time is the BioLife Solutions (BLFS) Q3 2025 earnings call on November 6, 2025?

The conference call and webcast start at 4:30 PM ET (1:30 PM PT) on November 6, 2025.

How can investors access the BioLife Solutions (BLFS) webcast for Q3 2025?

Access the live webcast via the company Investor Relations page at https://www.biolifesolutions.com/earnings.

What phone numbers can be used to join the BioLife Solutions (BLFS) Q3 2025 call?

Dial toll-free 1-833-630-0431 for U.S. callers or 1-412-317-1808 for international callers.

Will a replay of the BioLife Solutions (BLFS) Q3 2025 webcast be available after the call?

Yes. A webcast replay will be available about two hours after the call and archived for 90 days on the investor site.
Biolife Solutions Inc

NASDAQ:BLFS

BLFS Rankings

BLFS Latest News

BLFS Latest SEC Filings

BLFS Stock Data

1.20B
47.18M
2.11%
104.51%
8.23%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
BOTHELL